N/A
Completed N=1,209
An Observational Study of OPTIVE PLUS® for the Treatment of Dry Eye Disease
Dry Eye Syndromes
Source: ClinicalTrials.gov NCT01711424 ↗
Enrolled (actual)
1,209
Serious AEs
0.2%
Results posted
Mar 2014
Primary outcomePrimary: Number of Participants Very Satisfied or Satisfied With OPTIVE PLUS® — 356; 746 Participants
Summary
This is an observational study of OPTIVE PLUS® in patients with dry eye disease in a routine clinical setting. Treatment decisions are made by the physician and reflect the physician's current standard of care.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Very Satisfied or Satisfied With OPTIVE PLUS® |
356; 746 | — |
| SECONDARY Number of Participants Where Physician Was Very Satisfied or Satisfied With OPTIVE PLUS® |
367; 734 | — |
| SECONDARY Tear Break Up Time (TBUT) |
7.0; 10.0 | — |
| SECONDARY Schirmer Score |
8.0; 10.0 | — |
Eligibility Criteria
Inclusion Criteria
- Diagnosis of dry eye
- Physician decision to treat with OPTIVE PLUS® in accordance with the physician's standard practice
Exclusion Criteria
- None
Data sourced from ClinicalTrials.gov (NCT01711424). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.